BEhavioral Health Stratified Treatment (B.E.S.T.) to optimize transition to adulthood for youth with intellectual and/or developmental disabilities.

Youth with intellectual and/or developmental disabilities (IDD) often struggle with depression and anxiety, which adversely impacts transition to adulthood. Integrated behavioral health care coordination, wherein care coordinators and behavioral health specialists collaborate to provide systematic, cost-effective, patient-centered care, is a promising strategy to improve access to behavioral health services and address factors that impact transition to adulthood, including depression/anxiety symptoms. Current care coordination models (e.g., Title V Maternal and Child Health Bureau [MCHB]) do not include behavioral health services. The CHECK (Coordinated HealthCarE for Complex Kids) mental health model, hereby refined and renamed BEhavioral Health Stratified Treatment (B.E.S.T.), is a behavioral health intervention delivery program designed for integration into care coordination programs. This study aims to determine whether an integrated behavioral health care coordination strategy (i.e., MCHB care coordination plus B.E.S.T.) would be more acceptable and lead to better youth health and transition outcomes, relative to standard care coordination (i.e., MCHB care coordination alone). Results would guide future investment in improving outcomes for youth with IDD. This study is a two-arm randomized clinical trial of 780 transition-aged youth with IDD (13-20 years) to evaluate the comparable efficacy of MCHB Care Coordination alone vs. MCHB Care Coordination plus B.E.S.T. on the following outcomes: 1) decreased symptoms and episodes of depression and anxiety over time; 2) improved health behaviors, adaptive functioning and health related quality of life; 3) increased health care transition (HCT) readiness; and 4) improved engagement and satisfaction with care coordination among stakeholders.

Medication abortion within a student health care clinic: a review of the first 46 consecutive cases.

OBJECTIVE: Medication abortion with mifepristone and misoprostol has been available in the United States since 2000. The authors reviewed the first 46 medication abortion cases conducted at a university-based student health care clinic to determine the safety and feasibility of medication abortion in this type of clinical setting. PARTICIPANTS: Female patients presenting for medication abortion at a student health care clinic between October 1, 2006, and April 1, 2009. METHODS: Retrospective consecutive case review. RESULTS: Successful completion not requiring uterine aspiration occurred in 85% of the cases that were not lost to follow-up. Six cases (15%) required uterine aspiration for completion: 3 underwent uterine aspiration only; 3 had aspiration after failing an additional dose of misoprostol. Only 1 patient visited the emergency room. There were no hospitalizations. CONCLUSIONS: Medication abortion services in a student health care clinic are safe and feasible. However, additional treatment may be required with some patients.

Urinary symptoms after a routine pelvic exam.

PURPOSE: To determine if urinary symptoms are more common in women during the 4 weeks after a routine pelvic examination. METHODS: This was a 4-week, prospective, observational cohort study in a Family Medicine residency clinic at an urban university. Participants included women ages 18 to 40 years who identified themselves as sexually active and who presented for a routine pelvic examination. Controls were women presenting for other health maintenance with no pelvic examination. Independent variables included age, pelvic examination/no pelvic examination, intercourse frequency, and condom use. Dependent variables included dysuria and urinary frequency. Relative rates of dysuria and frequency were compared using χ(2) analysis. Mean rates of dysuria, frequency, intercourse, and condom use were compared using 2-tailed t tests. RESULTS: Sixty-three subjects and 87 controls completed the study. More subjects had days with dysuria (17% vs 7%; P < .01), days with frequency (27% vs 14%; P < .01), days with both dysuria and frequency (13% vs 3%; P < .01), and days with either dysuria or frequency (32% vs 17%; P < .01). Subjects had less intercourse than controls (1.6 times per week vs 2.2 times per week; P < .01) and used condoms less frequently (33% vs 41%; P < .01). CONCLUSIONS: Dysuria and urinary frequency are more common among sexually active women during the month after a routine pelvic examination.

Genitourinary infections after a routine pelvic exam.

PURPOSE: To determine if genitourinary problems are more common in women in the first 1 to 2 months after a routine pelvic examination. METHODS: This was a historical cohort study in 2 family medicine teaching clinics at an urban university. Participants included all women who received a Papanicolaou smear during calendar year 2006. Subjects included all participants for weeks 1 to 7 after their Papanicolaou smear. Controls were all participants in weeks 8 to 52 after their Papanicolaou smear. The independent variable was time after Papanicolaou smear, and dependent variables included frequency of visits for urinary complaints, diagnosed urinary tract infections (UTIs), vaginal complaints, diagnosed vaginitis, and sexually transmitted diseases. Relative frequencies compared using 2-tailed t tests. RESULTS: UTIs and urinary complaints were significantly more frequent during the first 7 weeks after a Papanicolaou smear compared with weeks 8 to 14, 8 to 48, and 8 to 52. The overall rate of UTIs was 7.33 per 100 person-years; the attributable risk during the first 7 weeks was 0.82 per 100 person-years, or 11% of observed UTIs. Combined Candidal and bacterial vaginitis was marginally more frequent during the first 7 weeks compared with weeks 8 to 48 and 8 to 52 only. The incidence of sexually transmitted diseases combined was 1.13 per 100 person-years, distributed evenly over the study period unrelated to time. CONCLUSIONS: The risk of UTI is increased in the 7 weeks after a Papanicolaou smear.